ClinicalTrials.gg
Active, not recruitingNCT07218731Updated Sep 24, 2026

Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses

An interventional study of Multifocal contact lenses and Spherical contact lenses in Presbyopia Correction and Presbyopia, sponsored by Ohio State University. Active, not recruiting at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Ohio State University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

The purpose of the study is to assess participant experience when wearing multifocal contact lenses compared to spherical contact lenses with reading glasses.

02

Conditions studied

  • Presbyopia Correction
  • Presbyopia

Browse trials for

03

In context

Presbyopia

336 studies on the registry are indexed under Presbyopia; 35 are open to participants now.

This study's planned enrollment of 30 is below the median of 61 across 276 interventional studies indexed under Presbyopia.

Browse Presbyopia studies →

Lead sponsor

Ohio State University is the lead sponsor of 663 studies on the registry; 148 are open to participants now.

Of its 67 completed or terminated interventional studies of FDA-regulated products, 49 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. At least 40 years of age.
  2. Ability to give .
  3. Subjects must have corrected distance visual acuity in both eyes equivalent to 20/25 or better at the screening visit.
  4. Require an add power of +0.75 D or greater when tested at 40cm.
  5. Good general health defined by medication use that has not changed within the last 30 days and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the Investigator.

Exclusion criteria

Exclusion Criteria:

  1. Current or active inflammation or infection as determined by the Investigator.
  2. Current eye disease, infection or inflammation that affects the surface of the eye such as but not limited to moderate or greater blepharitis and ocular allergy.
  3. History of refractive surgery.
  4. Known history of allergy or sensitivity to contact lens solutions and/or sodium fluorescein.
  5. Is pregnant or lactating or planning a pregnancy during enrollment of the study.
  6. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable.
  7. Have been diagnosed with dry eye previously
  8. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Multifocal contact lenses

    multifocal contact lenses

    Device: Multifocal contact lenses

  • Active comparator
    Spherical contact lenses with reading glasses

    spherical contact lenses used with reading glasses

    Device: Spherical contact lenses

Interventions

  • DeviceMultifocal contact lenses

    Multifocal contact lenses

  • DeviceSpherical contact lenses

    spherical contact lenses

06

What researchers measure

Primary outcomes

  1. Preference Survey

    Percentage of participants who prefer the multifocal lenses compared to spherical lenses with reading glasses.

    Time frame: 8 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — The data will not be shared with other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07218731
Responsible party
Jennifer Fogt (Principal Investigator, Ohio State University) — Principal investigator
First posted
Oct 20, 2025
Start date
Dec 8, 2025
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Sep 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion